Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
369.00
-6.63 (-1.77%)
Aug 8, 2025, 10:56 AM - Market open

Vertex Pharmaceuticals Stock Forecast

Stock Price Forecast

The 21 analysts that cover Vertex Pharmaceuticals stock have a consensus rating of "Buy" and an average price target of $496.76, which forecasts a 34.62% increase in the stock price over the next year. The lowest target is $405 and the highest is $575.

Price Target: $496.76 (+34.62%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$405$496.76$490$575
Change+9.76%+34.62%+32.79%+55.83%

Analyst Ratings

The average analyst rating for Vertex Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy101010988
Buy566666
Hold101011111110
Sell000000
Strong Sell000000
Total252627262524

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Canaccord Genuity
Canaccord Genuity
Hold
Maintains
$424$411
HoldMaintains$424$411+11.38%Aug 6, 2025
Guggenheim
Guggenheim
Strong Buy
Maintains
$558$546
Strong BuyMaintains$558$546+47.97%Aug 6, 2025
Wells Fargo
Wells Fargo
Buy
Upgrades
$460
BuyUpgrades$460+24.66%Aug 6, 2025
Truist Securities
Truist Securities
Strong Buy
Maintains
$520$490
Strong BuyMaintains$520$490+32.79%Aug 5, 2025
Scotiabank
Scotiabank
Hold
Maintains
$442$438
HoldMaintains$442$438+18.70%Aug 5, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
12.17B
from 11.02B
Increased by 10.40%
Revenue Next Year
13.46B
from 12.17B
Increased by 10.63%
EPS This Year
18.30
from -2.08
EPS Next Year
21.10
from 18.30
Increased by 15.30%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
6.21B7.57B8.93B9.87B11.02B12.17B13.46B14.72B
Revenue Growth
49.08%22.06%17.91%10.51%11.66%10.40%10.63%9.37%
EPS
10.299.0112.8213.89-2.0818.3021.1023.41
EPS Growth
128.16%-12.44%42.29%8.35%--15.30%10.93%
Forward PE
-----20.1617.4815.76
No. Analysts
-----373526
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue2025202620272029
High12.9B15.7B17.7B
Avg12.2B13.5B14.7B
Low11.5B11.7B11.6B

Revenue Growth

Revenue Growth2025202620272029
High
16.7%
29.1%
31.6%
Avg
10.4%
10.6%
9.4%
Low
4.5%
-3.8%
-13.9%

EPS Forecast

EPS2025202620272029
High19.7328.0533.75
Avg18.3021.1023.41
Low16.5617.3618.78

EPS Growth

EPS Growth2025202620272029
High-
53.2%
59.9%
Avg-
15.3%
10.9%
Low-
-5.2%
-11.0%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.